Pain And The Use Of Gabapentinoids In German Nursing Home Residents - Results From An Analysis Based On Statutory Health Insurance Data. Bantel C, Hoffmann F, Jobski K. J Pain Res. 2019 Nov 22;12:3175-3184. doi: 10.2147/JPR.S221579. https://www.n…

Warnung der FDA zu Gabapentin und Pregabalin: Bei Risikopersonen und in der Kombi mit Opioiden droht Atemdepression Gabapentin und Pregabalin in Kombination mit Opioiden oder mit anderen Arzneimitteln, welche das zentrale Nervensystem (ZNS) dämpfen…

USA. FDA In Brief: FDA requires new warnings for gabapentinoids about risk of respiratory depression “With the evolution of the opioid crisis, getting ahead of new concerns or addressing those that are already evident requires examining signs of mi…

The relationship between the reporting of euphoria events and early treatment responses to pregabalin: an exploratory post-hoc analysis. Parsons B, Freynhagen R, Schug S, Whalen E, Ortiz M, Bhadra Brown P, Knapp L. J Pain Res. 2019 Aug 22;12:2577-…

Intranasal Pregabalin Administration: A Review of the Literature and the Worldwide Spontaneous Reporting System of Adverse Drug Reactions. Elsayed M, Zeiss R, Gahr M, Connemann BJ, Schönfeldt-Lecuona C. Brain Sci. 2019 Nov 13;9(11). pii: E322. doi…

Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records…